Pfizer and Tris Pharma Agree to $41.5M Settlement with Texas Over ADHD Drug for Children

The Texas Attorney General announced on Wednesday that Pfizer (PFE) and privately owned Tris Pharma have reached a $41.5M settlement to resolve a lawsuit alleging that the duo provided an adulterated attention-deficit/hyperactivity disorder medication to the state.

According to the suit filed by Texas AG Ken Paxton in 2023, Pfizer (PFE) and Tris supplied an ADHD medication called Quillivant XR to children on Texas Medicaid despite the drug’s tendency to fail quality control tests due to faulty production methods.

Read more at MSN